A Trial to Test for Bioequivalence Between Two NN1250 [insulin degludec] Formulations in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 30 Sep 2015
At a glance
- Drugs Insulin degludec (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- 04 Nov 2009 Actual end date (Oct 2009) added as reported by ClinicalTrials.gov.
- 04 Nov 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 Sep 2009 New trial record